However, in the present study, this increase was found in the non‐COPD‐cohort, but not in the COPD cohort, though the interaction analysis did not reach statistical significance ( P =0.059).
← all excerpts
Ticagrelor Versus Clopidogrel in Patients With Acute Coronary Syndromes and Chronic Obstructive Pulmonary Disease: An Analysis From the Platelet Inhibition and Patient Outcomes (PLATO) Trial.
1
0.0590
0.0590